咨询与建议

限定检索结果

文献类型

  • 73 篇 期刊文献
  • 1 篇 会议

馆藏范围

  • 74 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 31 篇 工学
    • 6 篇 化学工程与技术
    • 5 篇 土木工程
    • 4 篇 材料科学与工程(可...
    • 3 篇 仪器科学与技术
    • 3 篇 石油与天然气工程
    • 2 篇 机械工程
    • 2 篇 动力工程及工程热...
    • 2 篇 控制科学与工程
    • 2 篇 建筑学
    • 2 篇 交通运输工程
    • 2 篇 生物医学工程(可授...
    • 1 篇 力学(可授工学、理...
    • 1 篇 光学工程
    • 1 篇 电气工程
    • 1 篇 电子科学与技术(可...
    • 1 篇 信息与通信工程
    • 1 篇 轻工技术与工程
    • 1 篇 航空宇航科学与技...
  • 22 篇 医学
    • 16 篇 临床医学
    • 3 篇 基础医学(可授医学...
    • 3 篇 医学技术(可授医学...
    • 2 篇 公共卫生与预防医...
  • 21 篇 农学
    • 19 篇 作物学
  • 4 篇 理学
    • 3 篇 化学
    • 1 篇 生物学
  • 3 篇 管理学
    • 2 篇 管理科学与工程(可...
  • 2 篇 教育学
    • 2 篇 教育学
  • 2 篇 艺术学
    • 2 篇 设计学(可授艺术学...
  • 1 篇 经济学
    • 1 篇 应用经济学
  • 1 篇 法学
    • 1 篇 社会学

主题

  • 10 篇 小麦
  • 3 篇 分子标记
  • 2 篇 蓝粒小麦
  • 2 篇 藜麦
  • 2 篇 多晶硅
  • 2 篇 lr34
  • 2 篇 分子标记检测
  • 2 篇 china
  • 2 篇 口腔衰弱
  • 2 篇 选育
  • 2 篇 lymphoma
  • 2 篇 lr26
  • 2 篇 基因型筛选
  • 2 篇 treatment
  • 2 篇 黔麦21号
  • 2 篇 赤霉病
  • 2 篇 chimeric antigen...
  • 2 篇 介入治疗
  • 2 篇 抗病基因
  • 1 篇 流固耦合

机构

  • 14 篇 贵州省旱粮研究所
  • 8 篇 贵州省农业科学院
  • 7 篇 贵州省农业科学院...
  • 5 篇 department of bi...
  • 3 篇 贵州省植保研究所
  • 3 篇 东南大学
  • 3 篇 贵州医科大学
  • 3 篇 四川大学华西医院
  • 3 篇 中国石油大学
  • 3 篇 贵州大学
  • 3 篇 石河子大学
  • 2 篇 wuchan zhongda d...
  • 2 篇 上海爵格工业工程...
  • 2 篇 zhejiang metals ...
  • 2 篇 江苏盐城市第一人...
  • 2 篇 天津大学
  • 2 篇 上海市健康促进中...
  • 2 篇 national clinica...
  • 2 篇 the state key la...
  • 2 篇 新疆大全新能源有...

作者

  • 22 篇 王伟
  • 21 篇 隋建枢
  • 21 篇 何庆才
  • 21 篇 陈天青
  • 13 篇 罗永露
  • 10 篇 吴文强
  • 10 篇 jianshu wei
  • 9 篇 weidong han
  • 5 篇 yao wang
  • 5 篇 zhiqiang wu
  • 4 篇 王艳丽
  • 3 篇 张建树
  • 3 篇 yelei guo
  • 3 篇 叶见曙
  • 3 篇 蒋微
  • 3 篇 吴建树
  • 3 篇 程斌
  • 3 篇 张剑书
  • 3 篇 chuan tong
  • 3 篇 曹建树

语言

  • 60 篇 中文
  • 14 篇 英文
检索条件"作者=jianshu wei"
74 条 记 录,以下是1-10 订阅
排序:
CART trials are going ahead
收藏 引用
Science China(Life Sciences) 2017年 第11期60卷 1276-1279页
作者: jianshu wei weidong han deparment of molecules&immunology chinese pla general hospitalmedical college of plaBeijing 100853China
For a long time,unresectable tumors were mainly controlled by chemotherapy,radiation therapy or kinase inhibitors,with which complete and durable remission was infrequent despite great advances *** recently,together w... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China
收藏 引用
Science China(Life Sciences) 2016年 第4期59卷 349-359页
作者: Can Luo jianshu wei weidong Han Institute of Basic Medicine/Bio-therapeutic Department Chinese PLA General Hospital Beijing 100853 China
T cell mediated adoptive immune response has been characterized as the key to anti-tumor immunity. Scientists around the world including in China, have been trying to harness the power of T cells against tumors for de... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Sol-Gel Preparation of LaNiO3 and Its Physical and Chemical Properties
收藏 引用
Journal of Rare Earths 2004年 第Z1期22卷 15-17页
作者: Lu jianshu Zhou Caiming wei Gaoyao Collage of chemical Engineering and Materials Zhejiang University of Technology Hangzhou 310014China Zhuji Bafang Battery Factory Zhuji 311801 China Collage of chemical Engineering and Materials Zhejiang University of Technology Hangzhou 310014China
LaNiO3 was synthesized by sol-gel method in which lanthanum nitrate and nickel nitrate were used as start materials and citric acid was used as complex for gel *** precursor was dried and subsequently heated at elevat... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Optimized collaboration of the first and third signals endows robust activity to T cells within the immunocompetent tumor microenvironment
收藏 引用
Cellular & Molecular Immunology 2023年 第11期20卷 1393-1394页
作者: jianshu wei Xin Lin weidong Han Changping Laboratory Yard 28Science Park RoadChangping District102206BeijingChina Department of Basic Medical Sciences Tsinghua University School of Medicine100084BeijingChina Tsinghua-Peking Center for Life Sciences 100084BeijingChina Department of Biotherapy the First Medical CenterChinese PLA General Hospital100853BeijingChina
CAR T-cell therapy has shown remarkable potential in the treatment of hematologic malignancies,and these successes have greatly motivated research on treatment of solid *** numerous clinical trials have been actively ... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Clinical development of CAR T cell therapy in China:2020 update
收藏 引用
Cellular & Molecular Immunology 2021年 第4期18卷 792-804页
作者: jianshu wei Yelei Guo Yao Wang Zhiqiang Wu Jian Bo Bin Zhang Jun Zhu weidong Han Department of Bio-Therapeutic The First Medical CenterChinese PLA General HospitalBeijing 100853China Department of Hematology The First Medical CenterChinese PLA General HospitalBeijing 100853China Department of Hematopoietic Stem Cell Transplantation The Fifth Medical CenterChinese PLA General HospitalBeijing 100071China Key Laboratory of Carcinogenesis and Translational Research Departments of LymphomaRadiology and Nuclear MedicinePeking University Cancer Hospital and InstituteBeijing 100036China
Chimeric antigen receptor(CAR)T-cell therapy has achieved significant success in the treatment of hematological *** recent years,fast-growing CAR T clinical trials have actively explored their potential application **... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Inducing immunogenic cell death in immuno-oncological therapies
收藏 引用
Chinese Journal of Cancer Research 2022年 第1期34卷 1-10页
作者: Dongdong Ti Xin Yan jianshu wei Zhiqiang Wu Yao Wang weidong Han Department of Bio-therapeutic the First Medical CenterChinese PLA General HospitalBeijing 100853China
Immunotherapy has revolutionized cancer treatment and substantially improved patient outcomes with respect to multiple types of ***,most patients cannot benefit from such therapies,mainly due to the intrinsic low immu... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Adaptive T cell immunotherapy in cancer
收藏 引用
Science China(Life Sciences) 2021年 第3期64卷 363-371页
作者: Dongdong Ti Miaomiao Bai Xiaolei Li jianshu wei Deyun Chen Zhiqiang Wu Yao Wang weidong Han Bio-therapeutic Department Chinese PLA General HospitalBeijing 100853China
Impaired tumor-specific effector T cells contribute to tumor progression and unfavorable clinical outcomes. As a compensatoryT cell-dependent cancer immunoediting strategy, adoptive T cell therapy (ACT) has achieved e... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies
收藏 引用
Signal Transduction and Targeted Therapy 2022年 第5期7卷 1634-1643页
作者: Xin Yan Deyun Chen Yao Wang Yelei Guo Chuan Tong jianshu wei Yajing Zhang Zhiqiang Wu weidong Han School of Medicine Nankai UniversityTianjinChina Department of Bio-therapeutic the First Medical CenterChinese PLA General HospitalBeijingChina National Clinical Research Center for Hematologic Diseases the First Affiliated Hospital of Soochow UniversitySuzhouChina
Despite the remarkable success of chimeric antigen receptor(CAR)T-cell therapy for treating hematologic malignancies,resistance and recurrence still occur,while the markers or mechanisms underlying this resistance rem... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Characteristics of premanufacture CD8^(+) T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
收藏 引用
Signal Transduction and Targeted Therapy 2023年 第11期8卷 5528-5538页
作者: Yao Wang Chuan Tong Yuting Lu Zhiqiang Wu Yelei Guo Yang Liu jianshu wei Chunmeng Wang Qingming Yang weidong Han Department of Bio-Therapeutic The First Medical CenterChinese PLA General HospitalBeijingChina Changping Laboratory BeijingPR China National Clinical Research Center for Hematologic Diseases The First Affiliated Hospital of Soochow UniversitySuzhouChina
Although chimeric antigen receptor(CAR)T cells have become an important treatment option for patients with relapsed/refractory B-cell malignancies,more than 60%of patients with diffuse large B-cell lymphoma(DLBCL)trea... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
收藏 引用
Signal Transduction and Targeted Therapy 2020年 第1期5卷 1295-1303页
作者: jianshu wei Yang Liu Chunmeng Wang Yajing Zhang Chuan Tong Guanghai Dai wei Wang John E.J.Rasko J.Joseph Melenhorst Wenbin Qian Aibin Liang weidong Han Department of Bio-therapeutic the First Medical CenterChinese PLA General Hospital100853 BeijingChina Department of Oncology the first Medical CenterChinese PLA General Hospital100853 BeijingChina State Key Laboratory of Biotherapy and Cancer Center West China HospitalSichuan UniversityChengdu 610041China Collaborative Innovation Center for Biotherapy Chengdu 610041China Department of Cell and Molecular Therapies Royal Prince Alfred HospitalSydneyNSW 2006Australia Gene and Stem Cell Therapy Program Centenary InstituteUniversity of SydneySydneyNSW 2006Australia Central Clinical School Faculty of Medicine and HealthThe University of SydneyCamperdownNSW 2050Australia Department of Pathology and Laboratory Medicine Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPA 19104-515USA Department of Hematology The Second Affiliated HospitalCollege of MedicineZhejiang UniversityHangzhou 310009China Department of Hematology Shanghai Tongji HospitalTongji University School of MedicineShanghai 200065China State Key Laboratory of Kidney Diseases National Clinical Research Center for Kidney Diseases100853 BeijingChina
Chimeric antigen receptor T(CAR T)cell therapy has demonstrated efficacy in the treatment of haematologic ***,the accompanying adverse events,the most common of which is cytokine release syndrome(CRS),substantially li... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论